AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 99 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.89 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $460,594 | -18.2% | 20,052 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $563,060 | -19.9% | 20,052 | -19.4% | 0.00% | -20.0% |
| Q3 2022 | $703,000 | +297.2% | 24,870 | +675.2% | 0.01% | +400.0% |
| Q2 2021 | $177,000 | +7.9% | 3,208 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $164,000 | +368.6% | 3,175 | +292.5% | 0.00% | – |
| Q4 2020 | $35,000 | +25.0% | 809 | 0.0% | 0.00% | – |
| Q3 2020 | $28,000 | -34.9% | 809 | 0.0% | 0.00% | – |
| Q2 2020 | $43,000 | +48.3% | 809 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | -94.8% | 809 | -92.3% | 0.00% | -100.0% |
| Q3 2016 | $555,000 | +26.1% | 10,510 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $440,000 | -29.4% | 10,510 | -31.5% | 0.00% | -33.3% |
| Q1 2016 | $623,000 | +1846.9% | 15,353 | +3046.1% | 0.00% | – |
| Q4 2015 | $32,000 | -34.7% | 488 | -6.3% | 0.00% | – |
| Q1 2015 | $49,000 | +2350.0% | 521 | +740.3% | 0.00% | – |
| Q1 2014 | $2,000 | – | 62 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |